A systematic review of the effect of TNF-alpha antagonists on lipid profiles in patients with rheumatoid arthritis.
Atherosclerosis plays a key role in cardiovascular disease in patients with rheumatoid arthritis (RA). Although therapy with TNF-alpha antagonists has resulted in dramatic improvement in the prognosis of RA, its effects on circulatory lipids are unclear. We conducted a systematic review of the literature to summarize the available evidence on lipid profile modification in patients with RA treated with TNF-alpha antagonists, with extensive searches in PubMed, the Cochrane Collaboration database (Central), and SCOPUS. Twenty-four observational studies met the inclusion criteria; 12 included only patients with RA treated with infliximab and three, patients with RA treated with adalimumab. The other nine included a mix of patients with various rheumatic diseases, or receiving one of several TNF-alpha antagonists. Eleven studies found a statistically significant increase in total cholesterol (TC) and high-density lipoprotein (HDL); six of 20 found significant increases in triglycerides (TG). Four of 13 studies found a statistical increase in low-density lipoprotein. No major changes were observed for ApoB/ApoA1 ratios. A small trend to increased TC was observed in patients receiving TNF-alpha antagonists, mostly due to an increase in HDL. There was a small trend to increased TG, and no changes in ApoB/ApoA1 ratio. The clinical impact of these findings is unclear, and further studies are needed to clarify the role of these lipid changes on cardiovascular morbidity in RA.
Pollono
Eduardo Nicolas
EN
Department of General Internal Medicine, Ambulatory Treatment and Emergency Care, The University of Texas M. D. Anderson Cancer Center, 1400 Pressler St, Unit 1465, Houston, TX 77030, USA.
Lopez-Olivo
Maria A
MA
Lopez
Juan Antonio Martinez
JA
Suarez-Almazor
Maria E
ME
D000068879:Adalimumab; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D001172:Arthritis, Rheumatoid / Q000097:blood* / Q000188:drug therapy; D002784:Cholesterol / Q000097:blood; D006801:Humans; D000069285:Infliximab; D008055:Lipids / Q000097:blood*; D008875:Middle Aged; D014280:Triglycerides / Q000097:blood; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D008055:Lipids; D014280:Triglycerides; D014409:Tumor Necrosis Factor-alpha; D002784:Cholesterol; D000069285:Infliximab; D000068879:Adalimumab
Z Ernahrungswiss. 1998;37 Suppl 1:66-74
9558731
Arthritis Rheum. 2005 Nov;52(11):3413-23
16255018
Ann Rheum Dis. 2009 Apr;68(4):546-51
18662929
N Engl J Med. 2008 Nov 20;359(21):2195-207
18997196
Int J Cardiol. 2008 Feb 29;124(2):172-8
17395297
J Rheumatol. 2008 Mar;35(3):398-406
18203326
Atherosclerosis. 2004 Nov;177(1):113-8
15488873
Semin Arthritis Rheum. 2005 Aug;35(1):18-23
16084220
J Rheumatol. 2007 Oct;34(10):1997-2004
17787045
Arthritis Rheum. 2004 Nov;50(11):3432-43
15529377
Clin Chim Acta. 2006 Mar;365(1-2):143-8
16176811
J Rheumatol. 2006 Dec;33(12):2440-6
17014005
Annu Rev Immunol. 1996;14:397-440
8717520
Arthritis Rheum. 2003 Nov;48(11):3061-7
14613267
Clin Rheumatol. 2007 Sep;26(9):1495-8
17237906
Ann Rheum Dis. 2007 Jul;66(7):958-61
17314120
Ann N Y Acad Sci. 2006 Jun;1069:414-9
16855168
Clin Rheumatol. 2008 Mar;27(3):281-7
18066611
JAMA. 2009 Nov 11;302(18):1993-2000
19903920
J Rheumatol. 2006 Feb;33(2):244-7
16465654
Endocr J. 2008 Mar;55(1):213-6
18270431
Circulation. 2002 Oct 22;106(17):2184-7
12390945
Ann Rheum Dis. 2005 Feb;64(2):303-5
15231512
Arthritis Rheum. 2004 Jun;50(6):1734-9
15188348
Wien Klin Wochenschr. 2002 Dec 30;114(23-24):1004-7
12635469
J Rheumatol. 2006 May;33(5):921-3
16541480
J Rheumatol. 2004 Sep;31(9):1746-53
15338494
Joint Bone Spine. 2008 Jan;75(1):22-4
17888710
Ann Rheum Dis. 2009 Aug;68(8):1316-21
18723565
Joint Bone Spine. 2009 Jan;76(1):117-8; author reply 118
19084458
Ann Rheum Dis. 2009 Apr;68(4):460-9
19286905
Ann Rheum Dis. 2009 Jun;68(6):868-72
18635596
Clin Exp Rheumatol. 2006 May-Jun;24(3):309-12
16870100
Ann Rheum Dis. 2007 Nov;66(11):1503-7
17472994
Clin Chim Acta. 2008 Mar;389(1-2):67-71
18155667
Ann Rheum Dis. 1997 Jun;56(6):374-7
9227167
Clin Rheumatol. 2007 Oct;26(10):1799-800
17646897
Lipids Health Dis. 2009 Dec 01;8:52
19951432
Clin Rheumatol. 2008 Jul;27(7):833-9
18075712
Med Clin (Barc). 2006 May 20;126(19):757
16759594
Scand J Rheumatol. 2006 Mar-Apr;35(2):107-11
16641043
Arthritis Rheum. 2002 Apr;46(4):862-73
11953961
Am J Med. 2002 Aug 15;113(3):188-93
12208376
Ann Rheum Dis. 2008 Jun;67(6):895-6
18474660
J Rheumatol. 2005 Feb;32(2):252-5
15693084
Curr Vasc Pharmacol. 2010 May;8(3):301-26
19758115